New Results
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses
View ORCID ProfileJoshua J. Sims, Sharon Lian, View ORCID ProfileJames M. Wilson
doi: https://doi.org/10.1101/2022.01.17.476672
Joshua J. Sims
1Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Sharon Lian
1Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
James M. Wilson
1Gene Therapy Program, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA

Article usage
Posted January 19, 2022.
High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses
Joshua J. Sims, Sharon Lian, James M. Wilson
bioRxiv 2022.01.17.476672; doi: https://doi.org/10.1101/2022.01.17.476672
Subject Area
Subject Areas
- Biochemistry (9550)
- Bioengineering (7071)
- Bioinformatics (24778)
- Biophysics (12568)
- Cancer Biology (9925)
- Cell Biology (14302)
- Clinical Trials (138)
- Developmental Biology (7932)
- Ecology (12080)
- Epidemiology (2067)
- Evolutionary Biology (15959)
- Genetics (10905)
- Genomics (14708)
- Immunology (9848)
- Microbiology (23587)
- Molecular Biology (9456)
- Neuroscience (50708)
- Paleontology (369)
- Pathology (1535)
- Pharmacology and Toxicology (2674)
- Physiology (4001)
- Plant Biology (8644)
- Synthetic Biology (2388)
- Systems Biology (6415)
- Zoology (1345)